Table 4.
Baseline immune response
Indicators | SAOLP | Placebo | Total | Statistic(t) | P value | |
---|---|---|---|---|---|---|
CD3 | N (Nmiss) | 18 (0) | 18 (0) | 36(0) | 0.53 | 0.597 |
Mean (SD) | 68.6 (10.4) | 66.9 (9.5) | 67.8 (9.9) | |||
Median (Q1,Q3) | 66.6 (59.4,76.3) | 63.8 (59.4,77.2) | 65.5 (59.4,76.7) | |||
Min, Max | 57.6, 89.7 | 54.4, 84.3 | 54.4, 89.7 | |||
CD4 | N (Nmiss) | 18 (0) | 18 (0) | 36 (0) | 1.19 | 0.244 |
Mean (SD) | 37.3 (8.3) | 34.5 (5.7) | 35.9 (7.2) | |||
Median (Q1,Q3) | 34.4 (32.4,43.6) | 34.4 (30.2,39.6) | 34.4 (30.7,39.8) | |||
Min, Max | 28.7, 63.0 | 26.9, 44.2 | 26.9, 63.0 | |||
CD8 | N (Nmiss) | 18 (0) | 18 (0) | 36(0) | −1.49 | 0.145 |
Mean (SD) | 25.4 (9.9) | 29.8 (8.0) | 27.6 (9.1) | |||
Median (Q1,Q3) | 24.2 (20.1,28.9) | 29.8 (22.3,36.5) | 26.1 (20.3,35.8) | |||
Min, Max | 10.9, 50.5 | 18.4, 43.6 | 10.9 (50.5) |